Keith W Woods - JoVE Visualize

Showing results (1-10 of 17) with videos related to

Pageof 2

Sort By:

Biochemistry|July 28, 2007

Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificityEric F Johnson, Kent D Stewart, Keith W Woods, et al.

Bioorganic & Medicinal Chemistry Letters|May 25, 2005

Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activityQun Li, Tongmei Li, Keith W Woods, et al.

Bioorganic & Medicinal Chemistry Letters|April 6, 2005

Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitorsQun Li, Keith W Woods, Weibo Wang, et al.

Neoplasia (New York, N.Y.)|August 2, 2008

Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expressionXuesong Liu, Yan Shi, Keith W Woods, et al.

Bioorganic & Medicinal Chemistry Letters|June 26, 2009

Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Julie Miyashiro, Keith W Woods, Chang H Park, et al.

Bioorganic & Medicinal Chemistry Letters|September 30, 2004

Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitorsQun Li, Gary T Wang, Tongmei Li, et al.

Bioorganic & Medicinal Chemistry Letters|February 14, 2012

Aminopyrimidinone cdc7 kinase inhibitorsKeith W Woods, Chunqiu Lai, Julie M Miyashiro, et al.

Neoplasia (New York, N.Y.)|December 8, 2005

Optimal classes of chemotherapeutic agents sensitized by specific small-molecule inhibitors of akt in vitro and in vivoYan Shi, Xuesong Liu, Edward K Han, et al.

Molecular Cancer Therapeutics|March 27, 2003

Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivativeStephen K Tahir, Michael A Nukkala, Nicolette A Zielinski Mozny, et al.

Journal of Medicinal Chemistry|April 5, 2002

Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluationLe Wang, Keith W Woods, Qun Li, et al.

Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:

Pageof 2

Biochemistry|July 28, 2007

Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificityEric F Johnson, Kent D Stewart, Keith W Woods, et al.

Bioorganic & Medicinal Chemistry Letters|May 25, 2005

Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activityQun Li, Tongmei Li, Keith W Woods, et al.

Bioorganic & Medicinal Chemistry Letters|April 6, 2005

Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitorsQun Li, Keith W Woods, Weibo Wang, et al.

Neoplasia (New York, N.Y.)|August 2, 2008

Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expressionXuesong Liu, Yan Shi, Keith W Woods, et al.

Bioorganic & Medicinal Chemistry Letters|June 26, 2009

Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Julie Miyashiro, Keith W Woods, Chang H Park, et al.

Bioorganic & Medicinal Chemistry Letters|September 30, 2004

Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitorsQun Li, Gary T Wang, Tongmei Li, et al.

Bioorganic & Medicinal Chemistry Letters|February 14, 2012

Aminopyrimidinone cdc7 kinase inhibitorsKeith W Woods, Chunqiu Lai, Julie M Miyashiro, et al.

Neoplasia (New York, N.Y.)|December 8, 2005

Optimal classes of chemotherapeutic agents sensitized by specific small-molecule inhibitors of akt in vitro and in vivoYan Shi, Xuesong Liu, Edward K Han, et al.

Molecular Cancer Therapeutics|March 27, 2003

Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivativeStephen K Tahir, Michael A Nukkala, Nicolette A Zielinski Mozny, et al.

Journal of Medicinal Chemistry|April 5, 2002

Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluationLe Wang, Keith W Woods, Qun Li, et al.

Pageof 2